series-a
Stage
About
Leuko Labs develops a noninvasive device called PointCheck™ that monitors white blood cell levels using light-based technology and AI, enabling at-home testing without blood draws primarily for cancer patients.
Explore Leuko Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.